NIAID
Through Agency-Funded Contractors, NIAID Aims to Help Bring Infectious Disease Tests to Market
Premium
The Diagnostics Development Services program is, so far, being used to help point-of-care testing firm Fluxergy bring to market a test for sexually transmitted infections.
NIH Awards $2.4M to Improve Syphilis Diagnostics
The 10 awards cover different novel diagnostic approaches as well as biomarker discovery and pre-analytical methods.
Kephera Nabs $5.7M in NIAID Grants for Lyme, Chagas Tests
The money will be used to aid development and clinical testing of assays to aid identification of Lyme disease and monitor response to treatment for Chagas disease.
Day Zero Diagnostics Wins $300K SBIR Grant for Fecal Microbiota Transplant Assay
The Boston firm will develop a sequencing-based safety and efficacy assay for fecal microbiota transplants called epiXact FMT.
Advanced BioScience Laboratories Wins NIH Contract for up to $12M
ABL will support the National Institute of Allergy and Infectious Diseases through the development, documentation, and production of custom assay components.